1. United Kingdom Stocks

  2. •

    Financial Services

  3. •

    Shell Companies
In Veritas Medical Diagnostics, Inc.

In Veritas Medical Diagnostics, Inc.

IVME
In Veritas Medical Diagnostics, Inc.US flagOther OTC
0.00
USD
-0.30
- -
60,234.00Market Cap
In Veritas Medical Diagnostics, Inc.
IVME
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2003
2004
2005
2006
2007
TTM
FRC
- -
32.05
8.37
11.54
- -
- -
Revenue per Share
-0.42
-42.86
-23.32
-16.78
-31.03
-25.95
Basic EPS, GAAP
-0.06
-34.23
-7.21
-6.18
-6.74
-3.47
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
-1.93
-111.95
-65.21
-78.72
-104.32
-112.84
Book Value per Share
-0.18
-96.38
-27.25
-42.93
-60.34
-67.76
Tangible Book Value per Share
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
1
1
1
- -
- -
Sales/Revenue/Turnover
-5,736.26
-133.72
-257.52
-75.45
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
-1
-2
-2
-4
-3
Net Income, GAAP
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-8,945.26
-133.72
-278.55
-145.45
- -
- -
Profit Margin (%)
- -
-2
-1
-2
-6
-7
Working Capital
- -
- -
2
2
1
1
LT Debt
- -
-2
-3
-5
-7
-8
Total Equity
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jul'07
Oct'08
Jan'08
ST Debt
3
3
4
LT Borrowings
1
1
1
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
- -
- -
- -
Market Capitalization
- -
- -
- -

Working Capital

FRC

•

in mil. unless spec.
Jul'07
Oct'08
Jan'08
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
6
7
7
Payables & Accruals
3
3
3
ST Debt
3
3
4
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
52.44%
Free Cash Flow
- -
- -
17.02%
Net Income, GAAP
- -
- -
98.55%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
- -
- -
- -
1
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
-2.57
-2.77
-2.78
- -
-16.78
2007
-7.59
-8.31
-5.77
- -
-31.03
2008
-5.44
-5.17
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2006
- -
- -
- -
- -
- -
2007
- -
- -
- -
- -
- -
2008
- -
- -
- -
- -
- -
Similar Companies
Advanced Merger Partners, Inc (AMPIW)
Global Blockchain Acquisition Corp. (GBBKW)
StoneBridge Acquisition Corporation (APAC)
American Acquisition Opportunity Inc. (AMAO)
Worldwide Webb Acquisition Corp. (WWACU)
FinTech Acquisition Corp. VI (FTVI)
Business
In Veritas Medical Diagnostics, Inc. operates as a development-stage entity, engaged in the research and advancement of medical devices tailored for near-patient diagnostic applications. The company’s shares are traded on the OTC Bulletin Board under the ticker IVME, though current trading activity suggests limited liquidity. Historically, its efforts have encompassed a range of solutions, including a prothrombin monitoring device designed for assessing blood coagulation in individuals at risk for cardiovascular events. Further developmental initiatives have involved a consumer-oriented device to predict the onset of labor for maternity planning, alongside a biomarker monitor intended for detecting various indicators such as those for heart conditions, HIV, cholesterol, and certain cancers. Additional projects have included a non-invasive continuous blood glucose monitor, a digital scanning alternative to traditional X-rays, a system for osteoporosis detection and bone mineral density assessment, and a handheld digital strip reader for immunoassay applications. The company continues its operations from Inverness, United Kingdom.